Navigation Links
Sword Diagnostics Announces Availability of Proprietary Detection Technology for Ultrasensitive Immunoassays.

CHICAGO, Jan. 14 /PRNewswire/ -- Sword Diagnostics announced today the launch of its proprietary Raman detection system for ultrasensitive immunoassays.  The system provides researchers with greater sensitivity which enables more accurate testing of low abundance markers.  These increases in performance could aid researchers in basic and clinical science research, drug discovery, and clinical diagnostics development.

"We find the resolution at low concentrations to be an exciting benefit in our ovarian cancer and infertility research," said Professor Judith Luborsky, Ph.D., Associate Dean for Research, College of Health Sciences, Director, Laboratory for Ovarian Cancer Research and Director, Rush Proteomics & Biomarkers Core Research Facility at Rush University Medical Center.  "The technology was easily integrated into existing tests with minimal optimization and provided excellent improvements.  In fact, we have included Sword technology in several grants we are currently applying for."

"We are pleased with the positive reception our technology has received from the market. The key opinion leaders have found it particularly useful for highly sensitive ELISAs," said Dave Dingott, founder and CEO of Sword Diagnostics.  "The Raman plate reader allows current ELISA users to continue using their 96-well format, making conversion to our technology extremely simple and cost effective."

About Sword Diagnostics

Sword Diagnostic's mission is to improve existing immunoassays by providing additional sensitivity to currently available antibody-based test as well as allowing researchers to monitor new markers that are not readily detectable with current technology.  This may lead to earlier and more accurate diagnosis of diseases such as cancer, cardiovascular disorders, and Alzheimer's disease.  Better diagnosis results in simpler treatments with more positive outcomes for patients and less costs.

Sword markets its technology for biomarker measurement for pharmaceutical drug discovery and academic life science researchers and will partner to develop clinical diagnostics assays.  The technical solution is an immunoassay detection system that uses Raman spectroscopy and a proprietary chemistry.  The system extends the sensitivity over current detection technologies while being easily incorporated into assays that use a peroxidase-based detection system.

SOURCE Sword Diagnostics Inc.



SOURCE Sword Diagnostics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. U.S. Patent Office Issues Sword Diagnostics Patent for Highly Sensitive Immunodetection Technology
2. Inverness Medical Innovations Offers to Acquire Standard Diagnostics
3. Frost & Sullivan Recognizes IntelligentMDx for Its Commitment to the Advancement of Healthcare and Diagnostics
4. Fujirebio Diagnostics Named Life Sciences Company of the Year
5. Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation
6. Roche Diagnostics Opens State-of-the-Art Training Center in California
7. Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition
8. Reportlinker Adds Molecular Diagnostics - A World Market Review
9. Scott Glenn Joins Exagen Diagnostics as Chairman and CEO
10. Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective
11. VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System
Post Your Comments:
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology and specialty ... Bracket eCOA (SM) 6.0, at the 52 nd ... in Philadelphia , Pennsylvania.  A demonstration of ... its kind to fully integrate with RTSM, will be held ... a flexible platform for electronic clinical outcomes assessments that is ...
Breaking Medicine Technology:
(Date:6/27/2016)... (PRWEB) , ... June 27, ... ... in the patient payment industry today announced its strategic partnership with Connance, ... system workflows. , The two companies’ proven, proprietary technology combine to provide ...
(Date:6/26/2016)... ... 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic treatment ... Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. This ... of the world’s leading providers of cereal and other breakfast foods. Its residents often ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are confused ... endometriosis. These women need a treatment plan to not only alleviate symptoms and ... help for preservation of fertility and ultimately achieving a pregnancy. The specialists at ...
(Date:6/25/2016)... ... , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize ... Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into ... Simply select a ProHand generator and drag it above media or text in the ...
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
Breaking Medicine News(10 mins):